Updated hep B vaccine more effective for people with HIV
December 13, 2024
December 13, 2024
ITHACA, New York, Dec. 13 -- Cornell University issued the following news:
A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, according to the results of an international study led by a Weill Cornell Medicine investigator.
The study, reported Dec. 1 in JAMA, showed that hepatitis B vaccine with a cytosine phosphoguanine ad . . .
A newer vaccine against hepatitis B virus was clearly superior to an older vaccine type in inducing a protective antibody response among people living with HIV who didn't respond to prior vaccination, according to the results of an international study led by a Weill Cornell Medicine investigator.
The study, reported Dec. 1 in JAMA, showed that hepatitis B vaccine with a cytosine phosphoguanine ad . . .